These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 31937925)

  • 1. MRI-based radiomics model for preoperative prediction of 5-year survival in patients with hepatocellular carcinoma.
    Wang XH; Long LH; Cui Y; Jia AY; Zhu XG; Wang HZ; Wang Z; Zhan CM; Wang ZH; Wang WH
    Br J Cancer; 2020 Mar; 122(7):978-985. PubMed ID: 31937925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiomics model based on preoperative gadoxetic acid-enhanced MRI for predicting liver failure.
    Zhu WS; Shi SY; Yang ZH; Song C; Shen J
    World J Gastroenterol; 2020 Mar; 26(11):1208-1220. PubMed ID: 32231424
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of a clinical-radiomics model to predict recurrence for patients with hepatocellular carcinoma after curative resection.
    Ren Y; Bo L; Shen B; Yang J; Xu S; Shen W; Chen H; Wang X; Chen H; Cai X
    Med Phys; 2023 Feb; 50(2):778-790. PubMed ID: 36269204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CT-based radiomics signature: a potential biomarker for preoperative prediction of early recurrence in hepatocellular carcinoma.
    Zhou Y; He L; Huang Y; Chen S; Wu P; Ye W; Liu Z; Liang C
    Abdom Radiol (NY); 2017 Jun; 42(6):1695-1704. PubMed ID: 28180924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A radiomics-based biomarker for cytokeratin 19 status of hepatocellular carcinoma with gadoxetic acid-enhanced MRI.
    Wang W; Gu D; Wei J; Ding Y; Yang L; Zhu K; Luo R; Rao SX; Tian J; Zeng M
    Eur Radiol; 2020 May; 30(5):3004-3014. PubMed ID: 32002645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretreatment prediction of immunoscore in hepatocellular cancer: a radiomics-based clinical model based on Gd-EOB-DTPA-enhanced MRI imaging.
    Chen S; Feng S; Wei J; Liu F; Li B; Li X; Hou Y; Gu D; Tang M; Xiao H; Jia Y; Peng S; Tian J; Kuang M
    Eur Radiol; 2019 Aug; 29(8):4177-4187. PubMed ID: 30666445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CT-based peritumoral radiomics signatures to predict early recurrence in hepatocellular carcinoma after curative tumor resection or ablation.
    Shan QY; Hu HT; Feng ST; Peng ZP; Chen SL; Zhou Q; Li X; Xie XY; Lu MD; Wang W; Kuang M
    Cancer Imaging; 2019 Feb; 19(1):11. PubMed ID: 30813956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiomics Analysis Based on Multiparametric MRI for Predicting Early Recurrence in Hepatocellular Carcinoma After Partial Hepatectomy.
    Zhao Y; Wu J; Zhang Q; Hua Z; Qi W; Wang N; Lin T; Sheng L; Cui D; Liu J; Song Q; Li X; Wu T; Guo Y; Cui J; Liu A
    J Magn Reson Imaging; 2021 Apr; 53(4):1066-1079. PubMed ID: 33217114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRI-Based Radiomics Signature: A Potential Biomarker for Identifying Glypican 3-Positive Hepatocellular Carcinoma.
    Gu D; Xie Y; Wei J; Li W; Ye Z; Zhu Z; Tian J; Li X
    J Magn Reson Imaging; 2020 Dec; 52(6):1679-1687. PubMed ID: 32491239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Machine-learning analysis of contrast-enhanced CT radiomics predicts recurrence of hepatocellular carcinoma after resection: A multi-institutional study.
    Ji GW; Zhu FP; Xu Q; Wang K; Wu MY; Tang WW; Li XC; Wang XH
    EBioMedicine; 2019 Dec; 50():156-165. PubMed ID: 31735556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of CT radiomics in prediction of early recurrence in hepatocellular carcinoma.
    Ning P; Gao F; Hai J; Wu M; Chen J; Zhu S; Wang M; Shi D
    Abdom Radiol (NY); 2020 Jan; 45(1):64-72. PubMed ID: 31486869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting the Outcome of Transcatheter Arterial Embolization Therapy for Unresectable Hepatocellular Carcinoma Based on Radiomics of Preoperative Multiparameter MRI.
    Sun Y; Bai H; Xia W; Wang D; Zhou B; Zhao X; Yang G; Xu L; Zhang W; Liu P; Xu J; Meng S; Liu R; Gao X
    J Magn Reson Imaging; 2020 Oct; 52(4):1083-1090. PubMed ID: 32233054
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CT radiomics nomogram for the preoperative prediction of severe post-hepatectomy liver failure in patients with huge (≥ 10 cm) hepatocellular carcinoma.
    Xiang F; Liang X; Yang L; Liu X; Yan S
    World J Surg Oncol; 2021 Dec; 19(1):344. PubMed ID: 34895260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative radiomics nomogram for microvascular invasion prediction in hepatocellular carcinoma using contrast-enhanced CT.
    Ma X; Wei J; Gu D; Zhu Y; Feng B; Liang M; Wang S; Zhao X; Tian J
    Eur Radiol; 2019 Jul; 29(7):3595-3605. PubMed ID: 30770969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocellular carcinoma: radiomics nomogram on gadoxetic acid-enhanced MR imaging for early postoperative recurrence prediction.
    Zhang Z; Jiang H; Chen J; Wei Y; Cao L; Ye Z; Li X; Ma L; Song B
    Cancer Imaging; 2019 May; 19(1):22. PubMed ID: 31088553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting the grade of hepatocellular carcinoma based on non-contrast-enhanced MRI radiomics signature.
    Wu M; Tan H; Gao F; Hai J; Ning P; Chen J; Zhu S; Wang M; Dou S; Shi D
    Eur Radiol; 2019 Jun; 29(6):2802-2811. PubMed ID: 30406313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiomics analysis enables recurrence prediction for hepatocellular carcinoma after liver transplantation.
    Guo D; Gu D; Wang H; Wei J; Wang Z; Hao X; Ji Q; Cao S; Song Z; Jiang J; Shen Z; Tian J; Zheng H
    Eur J Radiol; 2019 Aug; 117():33-40. PubMed ID: 31307650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiomics-based model using gadoxetic acid disodium-enhanced MR images: associations with recurrence-free survival of patients with hepatocellular carcinoma treated by surgical resection.
    Zhang L; Hu J; Hou J; Jiang X; Guo L; Tian L
    Abdom Radiol (NY); 2021 Aug; 46(8):3845-3854. PubMed ID: 33733337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A predictive model integrating deep and radiomics features based on gadobenate dimeglumine-enhanced MRI for postoperative early recurrence of hepatocellular carcinoma.
    Gao W; Wang W; Song D; Yang C; Zhu K; Zeng M; Rao SX; Wang M
    Radiol Med; 2022 Mar; 127(3):259-271. PubMed ID: 35129757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic resonance radiomics signatures for predicting poorly differentiated hepatocellular carcinoma: A SQUIRE-compliant study.
    Yang X; Yuan C; Zhang Y; Wang Z
    Medicine (Baltimore); 2021 May; 100(19):e25838. PubMed ID: 34106622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.